Results 11 to 20 of about 22,304 (253)

Levonorgestrel vs. Copper Intrauterine Devices for Emergency Contraception.

New England Journal of Medicine, 2021
BACKGROUND In the United States, more intrauterine device (IUD) users select levonorgestrel IUDs than copper IUDs for long-term contraception. Currently, clinicians offer only copper IUDs for emergency contraception because data are lacking on the ...
D. Turok, A. Gero, R. Simmons, J. Kaiser, G. Stoddard, C. Sexsmith, L. Gawron, J. Sanders   +7 more
semanticscholar   +1 more source

Association Between Doses of Levonorgestrel Intrauterine Systems and Subsequent Use of Psychotropic Drugs in France.

Journal of the American Medical Association (JAMA), 2022
This matched-cohort study uses data from the French National Health Insurance database to assess whether a 19.5-mg levonorgestrel intrauterine system, vs a 52-mg system, is associated with increased use of antidepressant, hypnotic, and anxiolytic ...
N. Roland, B. Baricault, Alain Weill, K. Bouillon, R. Dray-Spira, L. Duranteau, Mahmoud Zureik   +6 more
semanticscholar   +1 more source

Levonorgestrel intrauterine device as a non-invasive approach of abnormal uterine bleeding caused by cesarean scar defect [PDF]

Romanian Medical Journal, 2021
Cesarean scar defect, niche or isthmocele represents a poor healing in the anterior uterine wall after performing a cesarean section. The cesarean scar defect can be asymptomatic, or the patient could present abnormal uterine bleeding, chronic pelvic ...
Roxana-Elena Bohiltea, Bianca-Margareta Mihai, Valentin Varlas, Vlad Dima, Tiberiu Augustin Georgescu, Emilia-Maria Vladareanu, Nicolae Bacalbasa, Corina Grigoriu   +7 more
doaj   +1 more source

Effect of efavirenz on levonorgestrel concentrations among Malawian levonorgestrel implant users for up to 30 months of concomitant use: a subanalysis of a randomized clinical trial

Contraception: X, 2020
Objectives: Our primary objective was to compare geometric mean levonorgestrel concentrations between levonorgestrel implant users who were or were not taking the antiretroviral efavirenz, for up to 30 months after implant initiation.
Jennifer H. Tang, Nicole L. Davis, Amanda H. Corbett, Lameck Chinula, Mackenzie L. Cottrell, Yasaman Zia, Gerald Tegha, Frank Z. Stanczyk, Stacey Hurst, Mina C. Hosseinipour, Lisa B. Haddad, Athena P. Kourtis   +11 more
doaj   +1 more source

Comparison of levonorgestrel level and creamatocrit in milk following immediate versus delayed postpartum placement of the levonorgestrel IUD

BMC Women's Health, 2021
Background Breastfeeding and postpartum contraception critically influence infant and maternal health outcomes. In this pilot study, we explore the effects of timing and duration of postpartum levonorgestrel exposure on milk lipid and levonorgestrel ...
Niaree G. Hopelian, Rebecca G. Simmons, Jessica N. Sanders, Katherine Ward, Sabrina Malone Jenkins, Eve Espey, David K. Turok   +6 more
doaj   +1 more source

Silicone elastomer formulations for improved performance of a multipurpose vaginal ring releasing dapivirine and levonorgestrel

International Journal of Pharmaceutics: X, 2021
A dapivirine-releasing silicone elastomer vaginal ring for reducing women's risk of HIV acquisition has recently been approved. A next-generation multipurpose vaginal ring releasing dapivirine and levonorgestrel is currently in development, offering ...
Yahya H. Dallal Bashi, Diarmaid J. Murphy, Clare F. McCoy, Peter Boyd, Leeanne Brown, Matthew Kihara, François Martin, Nicole McMullen, Kyle Kleinbeck, Bindi Dangi, Patrick Spence, Bashir Hansraj, Brid Devlin, R. Karl Malcolm   +13 more
doaj   +1 more source

The Cost-Effectiveness of Emergency Hormonal Contraception with Ulipristal Acetate versus Levonorgestrel for Minors in France. [PDF]

PLoS ONE, 2015
OBJECTIVE:To evaluate the cost-effectiveness of ulipristal acetate and levonorgestrel in minors in France, and analyze whether it is worthwhile to provide ulipristal acetate to minors free of charge.
Ramona Schmid
doaj   +1 more source

Levonorgestrel intrauterine system for endometrial protection in women with breast cancer on adjuvant tamoxifen.

Cochrane Database of Systematic Reviews, 2020
BACKGROUND Adjuvant tamoxifen reduces the risk of breast cancer recurrence in women with oestrogen receptor-positive breast cancer. Tamoxifen also increases the risk of postmenopausal bleeding, endometrial polyps, hyperplasia, and endometrial cancer. The
Sally AD Romero, Katie Young, M. Hickey, H. Su   +3 more
semanticscholar   +1 more source

Insights into the Behavior of Triple-Negative MDA-MB-231 Breast Carcinoma Cells Following the Treatment with 17β-Ethinylestradiol and Levonorgestrel

Molecules, 2021
Oral contraceptives (OCs) are widely used due to their efficiency in preventing unplanned pregnancies and treating several human illnesses. Despite their medical value, the toxicity of OCs remains a public concern.
Sebastian Simu, I. Marcovici, A. Dobrescu, D. Malița, C. Dehelean, D. Coricovac, Flavius Olaru, G. Drăghici, D. Navolan   +8 more
semanticscholar   +1 more source

Effect of Oral Semaglutide on the Pharmacokinetics of Levonorgestrel and Ethinylestradiol in Healthy Postmenopausal Women and Furosemide and Rosuvastatin in Healthy Subjects

Clinical Pharmacokinetics, 2021
The first oral glucagon-like peptide-1 receptor agonist (GLP-1RA) comprises semaglutide co-formulated with the absorption enhancer, sodium N-(8-[2-hydroxybenzoyl] amino) caprylate (SNAC). Oral semaglutide may alter the pharmacokinetics of co-administered
Andreas B Jordy, M. Albayaty, Astrid Breitschaft, T. W. Anderson, E. Christiansen, Azadeh Houshmand-Øregaard, Easwaran Manigandan, T. Bækdal   +7 more
semanticscholar   +1 more source